CD44 and breast cancer: For instance, Jiang et al. demonstrated that ZEB1 knockout mouse-derived breast cancer cells present a decrease in the percentage of CD44+CD24−, as well as in the ALDH1+ population, accompanied by a reduction in the mammosphere formation capacity [52].